TipRanks
Advertisement
Advertisement
Agenus: No colorectal cancer recurrences observed at updated follow-up in trial
PremiumThe FlyAgenus: No colorectal cancer recurrences observed at updated follow-up in trial
2M ago
Agenus Modifies Loan and Issues Unregistered Equity
Premium
Company Announcements
Agenus Modifies Loan and Issues Unregistered Equity
2M ago
Agenus Grants CEO Large Performance-Based Stock Option Award
Premium
Company Announcements
Agenus Grants CEO Large Performance-Based Stock Option Award
2M ago
Agenus concentrates resources on ROBBIN, discontinues commitment to BATTMAN
PremiumThe FlyAgenus concentrates resources on ROBBIN, discontinues commitment to BATTMAN
3M ago
Agenus reports Q2 revenue $34.5M vs $25.7M last year
Premium
The Fly
Agenus reports Q2 revenue $34.5M vs $25.7M last year
3M ago
AGEN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AGEN Earnings this Week: How Will it Perform?
3M ago
Agenus price target raised to $30 from $23 at H.C. Wainwright
PremiumThe FlyAgenus price target raised to $30 from $23 at H.C. Wainwright
3M ago
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
Premium
The Fly
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
3M ago
Agenus Secures Strategic Financing to Advance Colon Cancer Program
Premium
Company Announcements
Agenus Secures Strategic Financing to Advance Colon Cancer Program
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―